James Peach

  • Citations Per Year
Learn More
TPS247 Background: Advances in understanding of the molecular pathology of cancer mean that treatments are increasingly being shown to preferentially benefit sub-groups of patients (stratified medicine). Molecular characterisation of tumours and normal tissue is now required for the testing and introduction of targetted therapies. However, the availability(More)
  • 1